Shelby Winzent-Oonk, PA-C

Sr. Instructor, Pediatrics-Heme/Onc and Bone Marrow Transplantation

Publications

  • Winzent-Oonk S, Staley A, Alami V, Bradley J, Harvey S, Pounds A, Kuldanek S, Pacenta H, Winters AC, McKinney C. Risk of transfusion-related iron overload varies based on oncologic diagnosis and associated treatment: Retrospective analysis from a single pediatric cancer center. Pediatr Blood Cancer. 2024 Aug 8;:e31254. [Epub ahead of print] PubMed PMID: 39118250
  • Hemenway MS, Winzent-Oonk S. NURS-23. THE ROLE OF THE ADVANCED PRACTICE PROVIDER IN THE PAIRED NORMAL SPECIMEN PROCESS AT A TERTIARY CARE CENTER. Neuro Oncol. 2024 Jun 18;26(Suppl 4):0. doi: 10.1093/neuonc/noae064.671. PMCID: PMC11183424.
  • Dorris K, Mettetal A, Hemenway M, Winzent-Oonk S, Dahl N, Levy JM, Prince E, McWilliams J, Jordan KR, Mirsky D, Hoffman L, Hankinson T. CP-12. PHASE 0 AND FEASIBILITY SINGLE-INSTITUTION CLINICAL TRIAL OF INTRAVENOUS TOCILIZUMAB FOR ADAMANTINOMATOUS CRANIOPHARYNGIOMA. Neuro Oncol. 2024 Jun 18;26(Suppl 4):0. doi: 10.1093/neuonc/noae064.050. PMCID: PMC11183541.
  • Winzent-Oonk S, Vallejos C, Hemenway M, Lindsay HB, Green AL. PALC-03. MEDICAL AID IN DYING: EXPERIENCE IN THE CENTER FOR CANCER AND BLOOD DISORDERS AT CHILDREN’S HOSPITAL COLORADO. Neuro Oncol. 2024 Jun 18;26(Suppl 4):0. doi: 10.1093/neuonc/noae064.703. PMCID: PMC11183639.
  • Dorris K, Mettetal A, Dahl N, Hemenway M, Winzent-Oonk S, Prince E, Vijmasi T, McWilliams J, Jordan K, Mirsky D, Hoffman L, Hankinson T. RARE-32. Phase 0 and feasibility single-institution clinical trial of intravenous tocilizumab for adamantinomatous craniopharyngioma. Neuro Oncol. 2022 Jun 3;24(Suppl 1):i17. doi: 10.1093/neuonc/noac079.057. PMCID: PMC9165090.
  • Winzent-Oonk, Shelby & Winters, Amanda & Pounds, Aneisia & Pacenta, Holly & Levy, Jean & McKinney, Christopher. (2022). EPID-06. Transfusion related iron overload in pediatric patients with CNS tumors. Neuro-Oncology. 24. i47-i48. 10.1093/neuonc/noac079.174.
  • Cho, Soohee & Miller, Kristen & Rowley, Jacqueline & Sabus, Ashley & Winzent-Oonk, Shelby & Bray, Stacy & Koo, Jane & Levy, Jean. (2022). OTHR-03. Oxaliplatin as a hearing-sparing alternative to carboplatin in tandem autologous stem cell transplants in pediatric CNS malignancy. Neuro-Oncology. 24. i147-i147. 10.1093/neuonc/noac079.542.
  • Hemenway M, Dorris K, Foreman N, Winzent S, Kissell E, Kasson J. SWK-10. Survivorship: Education, Clinical Guidelines, and Transition to Adult Care. Neuro Oncol. 2022 Jun 3;24(Suppl 1):i182–3. doi: 10.1093/neuonc/noac079.682. PMCID: PMC9165175.
  • Winzent S, Dahl N, Hemenway M, Lovria R, Dorris K. OTHR-16. CONCURRENT USE OF APREPITANT AND IFOSFAMIDE IN PEDIATRIC CANCER PATIENTS. Neuro Oncol. 2020 Dec 4;22(Suppl 3):iii424. doi: 10.1093/neuonc/noaa222.637. PMCID: PMC7715537.
  • Sabus A, Winzent S, Hemenway M, Levy JM, Foreman N. DDEL-06. DRUG INTERACTION BETWEEN EVEROLIMUS AND CANNABIDIOL IN PEDIATRIC PATIENTS WITH SUBEPENDYMAL GIANT CELL ASTROCYTOMAS: A SINGLE INSTITUTION EXPERIENCE. Neuro Oncol. 2020 Dec 4;22(Suppl 3):iii284. doi: 10.1093/neuonc/noaa222.041. PMCID: PMC7715614.
  • Winzent S, Sabus A, Hemenway M, Nellan A, Mulcahy-Levy J. MODL-01. SAFETY IN CONCOMITANT USE OF MEK AND BRAF INHIBITORS WITH BEVACIZUMAB. Neuro Oncol. 2020 Dec 4;22(Suppl 3):iii411–2. doi: 10.1093/neuonc/noaa222.578. PMCID: PMC7715474.
  • Winzent-Oonk, S, Winters A, Pounds A, Pacenta H, McKinney C. Improving Screening for Transfusion Related Iron Overload in the CCBD. Poster, CHCO Quality Symposium. July 2018.
  • Pacenta, H., Coughlin, R., Winzent, S., Hilden, J. M., Thornhill, D., Branchford, B. R., ... & McKinney, C. M. (2017). Optimizing Iron Overload Screening in a Pediatric Center for Cancer and Blood Disorders. Blood, 130, 2099.
View All (13 Total) View Less

Practice Locations

Children's Hospital Colorado Anschutz Medical Campus
13123 East 16th Ave
Aurora, CO 80045
720-777-1234

Specialty Information

Specialties
  • Pediatric Hematology / Oncology, Board Certification

School of Medicine

CU Anschutz

Fitzsimons Building

13001 East 17th Place

Campus Box C290

Aurora, CO 80045


303.724.5375